Month: July 2021

On June 16, 2021, Taro Canada announced the introduction of its budesonide inhalation suspension, a generic version of Pulmicort Respules (budesonide) inhalation suspension by AstraZeneca. […]

According to a 2018 report published by the CDC (Centers for Disease Control and Prevention), more than 87% of adults ages 65+ take at least […]